Ignite Creation Date:
2025-12-24 @ 10:12 PM
Ignite Modification Date:
2026-03-22 @ 12:44 AM
Study NCT ID:
NCT00004635
Status:
COMPLETED
Last Update Posted:
2018-05-22
First Post:
2000-02-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
000080
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None